We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
3226
Allogene Therapeutics
ALLO
$694M
$2K ﹤0.01%
+74
New +$2.06K
AMX icon
3227
America Movil
AMX
$71.2B
$2K ﹤0.01%
+144
New +$2.13K
APM
3228
DELISTED
Aptorum Group
APM
$2K ﹤0.01%
6
-2
-25% -$426
APPN icon
3229
Appian
APPN
$2.48B
$2K ﹤0.01%
55
+50
+1,000% +$1.71K
APPS icon
3230
Digital Turbine
APPS
$1.74B
$2K ﹤0.01%
442
-493
-53% -$1.98K
APYX icon
3231
Apyx Medical
APYX
$171M
$2K ﹤0.01%
+269
New +$1.46K
ARDC
3232
Are Dynamic Credit Allocation Fund
ARDC
$298M
$2K ﹤0.01%
161
-939
-85% -$14.2K
ASX icon
3233
ASE Group
ASX
$82.2B
$2K ﹤0.01%
+537
New +$2.24K
AYTU icon
3234
AYTU BioPharma
AYTU
$25.3M
$2K ﹤0.01%
+4
New +$1.52K
BCML icon
3235
BayCom
BCML
$333M
$2K ﹤0.01%
+111
New +$2.53K
BFST icon
3236
Business First Bancshares
BFST
$1.03B
$2K ﹤0.01%
63
-17
-21% -$424
BNDX icon
3237
Vanguard Total International Bond ETF
BNDX
$82.2B
$2K ﹤0.01%
34
-1
-3% -$56
SLAI
3238
DELISTED
SOLAI Ltd ADS
SLAI
$2K ﹤0.01%
3
-6
-67% -$4.73K
CAAS icon
3239
China Automotive Systems
CAAS
$133M
$2K ﹤0.01%
681
-604
-47% -$1.56K
CCOI icon
3240
Cogent Communications
CCOI
$508M
$2K ﹤0.01%
+33
New +$1.89K
CELC icon
3241
Celcuity
CELC
$4.52B
$2K ﹤0.01%
+61
New +$1.34K
CENTA icon
3242
Central Garden & Pet Co Class A
CENTA
$2.44B
$2K ﹤0.01%
125
-218
-64% -$4.38K
CLBK icon
3243
Columbia Financial
CLBK
$1.13B
$2K ﹤0.01%
+100
New +$1.54K
CLLS
3244
Cellectis
CLLS
$285M
$2K ﹤0.01%
130
-5,354
-98% -$95.6K
CNCR
3245
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$2K ﹤0.01%
+87
New +$1.79K
CNVS icon
3246
Cineverse
CNVS
$65.6M
$2K ﹤0.01%
+81
New +$2.84K
CRNT icon
3247
Ceragon Networks
CRNT
$201M
$2K ﹤0.01%
579
-1,861
-76% -$6.09K
CVLG icon
3248
Covenant Logistics
CVLG
$872M
$2K ﹤0.01%
+316
New +$2.77K
DNLI icon
3249
Denali Therapeutics
DNLI
$3.97B
$2K ﹤0.01%
115
-713
-86% -$16K
DNTH icon
3250
Dianthus Therapeutics
DNTH
$6.09B
$2K ﹤0.01%
8
-42
-84% -$10.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.